Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:
Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs
As of March 31, 2023 (In thousands) Total  (Level 1)  (Level 2)  (Level 3)
Assets
Cash equivalents:
Corporate debt securities $ 1,063  $ —  $ 1,063  $ — 
Money market funds and other 1,080,003  1,080,003  —  — 
Marketable securities:
Corporate debt securities 460,142  —  460,142  — 
Municipal securities 35,884  —  35,884  — 
Sovereign securities 5,016  —  5,016  — 
U.S. Government agency securities 117,370  117,370  —  — 
U.S. Treasury securities 424,723  389,126  35,597  — 
Equity securities 19,839  19,839  —  — 
Total cash equivalents and marketable securities(1)
2,144,040  1,606,338  537,702  — 
Other current assets:
Derivative assets 20,291  —  20,291  — 
Other non-current assets:
Executive Deferred Savings Plan 245,090  192,854  52,236  — 
Total financial assets(1)
$ 2,409,421  $ 1,799,192  $ 610,229  $ — 
Liabilities
Derivative liabilities $ (13,196) $ —  $ (13,196) $ — 
Contingent consideration payable (19,299) —  —  (19,299)
Total financial liabilities $ (32,495) $ —  $ (13,196) $ (19,299)
________________
(1) Excludes cash of $315.5 million held in operating accounts and time deposits of $430.7 million (of which $172.0 million were cash equivalents) as of March 31, 2023.
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows: 
Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs
As of June 30, 2022 (In thousands) Total (Level 1) (Level 2) (Level 3)
Assets
Cash equivalents:
Corporate debt securities $ 922  $ —  $ 922  $ — 
Money market funds and other 948,027  948,027  —  — 
U.S. Treasury securities 22,485  —  22,485  — 
Marketable securities:
Corporate debt securities 472,047  —  472,047  — 
Municipal securities 60,724  —  60,724  — 
Sovereign securities 5,990  —  5,990  — 
U.S. Government agency securities 91,116  91,116  —  — 
U.S. Treasury securities 348,026  344,559  3,467  — 
Equity securities 11,035  11,035  —  — 
Total cash equivalents and marketable securities(1)
1,960,372  1,394,737  565,635  — 
Other current assets:
Derivative assets 40,311  —  40,311  — 
Other non-current assets:
Executive Deferred Savings Plan 224,188  176,928  47,260  — 
Total financial assets(1)
$ 2,224,871  $ 1,571,665  $ 653,206  $ — 
Liabilities
Derivative liabilities $ (34,315) $ —  $ (34,315) $ — 
Deferred payments (2,350) —  —  (2,350)
Contingent consideration payable (23,674) —  —  (23,674)
Total financial liabilities $ (60,339) $ —  $ (34,315) $ (26,024)
________________
(1) Excludes cash of $472.8 million held in operating accounts and time deposits of $274.9 million (of which $140.7 million were cash equivalents) as of June 30, 2022.